We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BIOIDENT Announces Lab-on-a-Chip System Based on Printed Semiconductor Technology
Product News

BIOIDENT Announces Lab-on-a-Chip System Based on Printed Semiconductor Technology

BIOIDENT Announces Lab-on-a-Chip System Based on Printed Semiconductor Technology
Product News

BIOIDENT Announces Lab-on-a-Chip System Based on Printed Semiconductor Technology


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BIOIDENT Announces Lab-on-a-Chip System Based on Printed Semiconductor Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BIOIDENT Technologies Inc. has announced the functional lab-on-a-chip system, the PhotonicFlow™ System. The first application of the PhotonicFlow System is comprised of a multiwell chip, a handheld device controller and readout software.

The PhotonicFlow System is based on BIOIDENT’s PhotonicLab Platform, which combines printed semiconductors with various lab-on-chip technologies.

With this breakthrough technology development, BIOIDENT’s customers and partners now have the ability to develop disposable lab-on-a-chip solutions that can eliminate the need for expensive and bulky readout systems.

The PhotonicFlow System application expands upon BIOIDENT’s previously announced nanotiter plate prototype - a 1”x3” multi-well chip with a fully integrated photodetector array based on printed semiconductor technology with a dedicated pixel under each well on the chip.

This array converts light into electrical signals, enabling real-time analysis of multiple agents. The new components of the PhotonicFlow System are the handheld device controller for electronic readout of the signals from the photodetector and the readout software for analytics and calibration.

“The PhotonicFlow System is a significant milestone for BIOIDENT and for the industry,” said Dr. Wasiq Bokhari, CEO for BIOIDENT Technologies.

“This system provides our partners a fast path to deliver new point of care tests that are easy to use and cost-effective for end users. By integrating the PhotonicFlow System with their existing devices, assays and reagents, our partners can rapidly develop highly sensitive and multiplexed diagnostics across multiple markets. This is truly a next generation mobile lab that is set to transform current diagnostics and analysis testing across multiple markets,” Bokhari continued.

BIOIDENT’s PhotonicLab Platform uses printed semiconductor-based technology to print light detection and electronics capabilities directly onto any surface, including glass and plastic materials, enabling on-chip analysis and diagnostics.

In addition, the company uses existing assays and reagents and established testing protocols to deliver real-time and in-situ, multi-parameter detection capabilities for all categories of chemical and biological analytes.

BIOIDENT’s printing process can also be used to create a wide variety of existing in-vitro diagnostic devices, opening up new opportunities and applications for real-time analysis of chemical and biological substances.

“The combination of NANOIDENT’s SEMICONDUCTOR 2.0 Platform technology with our highly specialized, market-specific testing capabilities has resulted in a new PhotonicFlow System that is unique in the market today,” said Max Sonnleitner, CTO for BIOIDENT Technologies Inc.

“We look forward to working with our partners to develop exciting new applications across the healthcare, water testing and biological and chemical threat detection markets.”

Advertisement